GOV.UK gov.uk 2026-07-06 10:07

MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced Merkel cell skin cancer

Merkel cell carcinoma (MCC) is a rare and aggressive type of skin cancer that develops from Merkel cells, specialised neuroendocrine cells found in the top layer of the skin.  

Read full article at GOV.UK ↗

This summary is provided by Daily Junction. The original article is published by GOV.UK and all rights remain with the original publisher.

Related coverage on Daily Junction

Daily Briefing

The day's biggest stories in one free email. Join 12,688 readers.